RB_0003-01
Showing 1 - 25 of 4,175
Melanoma Trial in Germany (Lipo-MERIT)
Active, not recruiting
- Melanoma
- Lipo-MERIT
-
Frankfurt, Germany
- +3 more
Jan 5, 2023
Ventral Hernia Trial in Ghent (quality of life questionnaires)
Recruiting
- Ventral Hernia
- quality of life questionnaires
-
Ghent, East Flanders, BelgiumGhent University Hospital
Aug 27, 2021
Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)
Completed
- Ependymoma
- +9 more
- Nivolumab
- NKTR-214
-
Little Rock, Arkansas
- +17 more
Dec 8, 2022
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (QBW251, Placebo, COPD maintenance background therapy)
Completed
- Pulmonary Disease, Chronic Obstructive
- QBW251
- +2 more
-
Andalusia, Alabama
- +147 more
Jul 27, 2022
Diabetic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)
Completed
- Diabetic Kidney Disease
- Finerenone (BAY94-8862)
- Placebo
-
Birmingham, Alabama
- +974 more
Apr 13, 2022
Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
- LDRT+CFRT
- +2 more
-
Shanghai, China
- +1 more
Aug 3, 2023
Diagnostic Agent Adverse Reaction, Radiation Exposure Trial in New Haven (18F-LY3950321, PET Scan)
Recruiting
- Diagnostic Agent Adverse Reaction
- Radiation Exposure
- 18F-LY3950321
- PET Scan
-
New Haven, ConnecticutInvicro, LLC
Mar 20, 2023
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (CSJ117, Placebo)
Recruiting
- Pulmonary Disease, Chronic Obstructive
- CSJ117
- Placebo
-
Andalusia, Alabama
- +59 more
Jul 29, 2022
Porto-Venous Radiomics in Pancreatic Cancer
Recruiting
- Pancreatic Cancer
- Non-Interventional
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Jan 17, 2023
Healthy Trial in Adelaide (TR-01-XRR (1), TR-01-XRR (2), TR-01-XRR (3))
Not yet recruiting
- Healthy
- TR-01-XRR (1)
- +6 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Feb 3, 2023
Outcome of GI Cancer in NCKUH
Completed
- Collection of Real-world Data in a Single Institute
-
Tainan, Taiwan
- +1 more
Jan 17, 2023
Email Reminders on No-Show Rates for Appointments inUrology
Recruiting
- No-Show Patients
- Reminder Systems
- E-Mail Reminder
-
Caba, ArgentinaHospital Italiano de Buenos
Nov 2, 2023
Liposarcoma, Dedifferentiated Trial in New York (SPH4336)
Not yet recruiting
- Liposarcoma, Dedifferentiated
-
New York, New YorkColumbia University Medical Center
Oct 13, 2022
COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Tozorakimab
- Placebo
-
Lincoln, California
- +113 more
Feb 15, 2023
COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)
Recruiting
- COVID-19
- +3 more
- RQ-001
- Placebo
-
Cullman, Alabama
- +8 more
Sep 28, 2023
Joint Pain Trial in Mumbai, Nashik, Panvel (E-PR-01 (Low dose), E-PR-01 (High Dose), Placebo)
Not yet recruiting
- Joint Pain
- E-PR-01 (Low dose)
- +2 more
-
Mumbai, Maharashtra, India
- +3 more
Apr 24, 2023
Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B
Active, not recruiting
- Hemophilia B
- AAV5-hFIX
-
Berlin, Germany
- +5 more
Jan 17, 2023
Multi-channel Time-resolved Functional Near Infrared
Not yet recruiting
- Stroke
- Cerebral Oxygenation
- multichannel time-resolved (tr) functional near infrared spectroscopy (fNIRS) (tr-fNIRS)
- (no location specified)
Feb 21, 2023
How do Perceptions of Coronavirus Disease Risk Influence Health
Recruiting
- Pregnancy Related
-
Vancouver, British Columbia, Canada
- +1 more
Jan 9, 2023
Cancer Patient Perspectives During COVID-19
Active, not recruiting
- Breast Cancer
-
Aurora, ColoradoColorado Research Center
Nov 17, 2022
Adverse Events Trial in United States (Irrisept, Standard of Care)
Completed
- Adverse Events
- Irrisept
- Standard of Care
-
Tucson, Arizona
- +16 more
May 4, 2022